SUMMARY We have investigated the correlation of 24 h and 48 h faecal Indium-lll excretion with each other and with several clinical activity indices for Crohn's disease (CD): Crohn's disease activity index (CDAI), activity index (AI), simple index (SI), Oxford score, and laboratory parameters, such as ESR, serum albumin, orosomucoid, C-reactive protein, alpha-l-antitrypsin (at,-AT) faecal concentration, and al-AT clearance in 58 CD patients (37 with small bowel and 21 with colonic disease). A significant correlation was found between 24 and 48 h faecal Indium-111 excretion for small bowel (r=0.708, p<00001) and colonic disease (r=0.994, p<00001). The median faecal Indium-111 excretion for colonic involvement (4%; 0-15-50% median and range) was significantly (p<00005) higher than that for small bowel disease (0.45%; 0.03-29%). No significant correlation was found between faecal Indium-111 excretion and any activity index in the patients with small bowel disease, while in the group of patients with colonic localisation only the AI showed a significant correlation (r=0-593, p<002). Faecal Indium-ill excretion was significantly correlated with al-AT clearance (r=0.712, p<00001) and faecal ctl-AT concentration (r=0'750, p<00001) in small bowel and in colonic localisation (r=0-530, p<0O02 and r=0.444, p<005). Serum albumin was significantly correlated only in the group of patients with colonic disease (r= -0.593, p<005). The present study shows poor agreement between activity indices, serum parameters of activity and faecal Indium-111 excretion. As a good correlation was found with the al-clearance, which reflects losses into the gut, these results may suggest that faecal Indium excretion does not only reflect activity of inflammation, but may relate to the extent of intestinal ulceration.
During the last decade a number of clinical indices have been developed to try to standardise disease activity`but because most are based on a subjective grading of signs and symptoms, none is considered as the final ideal index.
Measurement of clearance and faecal concentration of alpha-1-antitrypsin (a,-AT) has been successfully used to estimate the degree of intestinal inflammation.> More recently, the quantification of faecal excretion of intravenously administered autologous Indium-111 tropolonate labelled granulocytes has been introduced as a highly specific parameter for bowel inflammation, independent of the subjective Crama-Bohbouth, Pefia, Biemond, Verspaget, Blok, Arndt, Weterman, Pauwels, and Lamers
Correlation was evaluated using the two tailed Pearson's correlation coefficient.
Results
As shown in Figures 1 and 2 a significant correlation was found between 24 and 48 h faecal excretion for colonic disease (r=0.994) and for small bowel localisation (r=0-708). We therefore used 24 h faecal Indium-111 excretion for the analysis of our results.
The median 24 h Indium-111 faecal excretion was significantly higher (p<00005) in patients with colonic involvement (median 4%, range 0.15-50%) than in the group of patients with small bowel disease (0.44%,0.03-2.9%). Table 1 shows the correlation between Indium-111 faecal excretion and the activity indices CDAI, AI, SI and Oxford score in the groups of patients with colonic and small bowel localisation separated and combined. As shown in this Table no significant correlation was found between Indium-111 excretion and any activity index for patients with small bowel disease. A significant correlation with the AI (p<0.05), however, was found for colonic localisation and when the groups were analysed combined (p<0-001). Table 2 shows the correlation between faecal Indum-111 excretion and the various laboratory parameters (ESR, C-reactive protein, serum albumin and orosomucoid), the cal-AT clearance, and al-AT faecal concentration. A significant correlation was found with al-AT clearance and faecal concentration in patients with either localisation (p<0002) (Figs. 3,4) .
The al-AT clearance and a1-AT faecal concentration were higher in the group with colonic disease (median 193, range 100-426 ml/24 h; median 8, range 7 0-26-0 mg-g) than in the group with ileal involve- Fischbach et al'-found a significant correlation between Indium-111 excretion and serum orosomucoid in 27 CD patients. We also found a significant correlation in our patients but when the patients were analysed according to localisation no significant correlation was observed.
The faecal Indium-Ill excretion showed a poor correlation with the activity indices or serum parameters of activity, such as ESR, CRP, and orosomucoid. A good correlation was found, however, with the a,-AT clearance, which reflects losses into the gut. These results may suggest that faecal IndiumIll excretion does not only reflect activity of inflammation, but may be also related to the extent of intestinal ulceration.
Future prospective studies should be designed to assess the different contribution of degree of inflammation and extent of ulceration on the faecal excretion of Indium-l 1 and the clearance of aI-AT. 
